IL6 and polycystic ovary syndrome: The IL-6 levels remained significantly higher in the PCOS patients compared to the controls (SMD = 0.37, 95% CI = 0.22–0.53, P<0.001), but the heterogeneity decreased significantly (I2 = 23% and P = 0.200).